{"filing":{"accession_number":"0001077183-26-000045","cik":"0001077183","ticker":"NEO","company_name":"NEOGENOMICS INC","form":"8-K","filing_date":"2026-07-20","report_date":null,"primary_document":"neo-20260720.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1077183/000107718326000045/neo-20260720.htm"},"events":[{"id":18884,"run_id":16984,"accession_number":"0001077183-26-000045","anchor_item_number":"8.01","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"summary":"NeoGenomics settled a Department of Justice/Office of Inspector General investigation concerning consulting services provided under its Laboratory Collaboration Initiative program, agreeing to pay $9,813,260 plus interest. The settlement resolves a matter the company self-disclosed in November 2021 and for which it had previously accrued $11.2 million in reserves, materially affecting the company's regulatory compliance and financial position.","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-07-20","form":"8-K","submitted_at":null,"items":[{"id":17831,"accession_number":"0001077183-26-000045","item_number":"7.01","item_title":null,"event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.85,"reasoning":"NeoGenomics announced settlement of a DOJ/OIG investigation concerning consulting services provided under its Laboratory Collaboration Initiative program. The company agreed to pay $9,813,260 plus interest, resolving a matter it had self-disclosed in November 2021 and for which it had previously accrued $11.2 million in reserves. This is a material legal settlement with a government agency that would affect a reasonable investor's assessment of the company's regulatory compliance and financial position, but does not fit the specific \"material_litigation\" category (which typically involves private lawsuits or settlements) — it is instead a regulatory settlement, making \"legal_other\" the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T21:28:39.785133+00:00","company_name":"","ticker":null,"filing_date":""},{"id":17832,"accession_number":"0001077183-26-000045","item_number":"8.01","item_title":null,"event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"NeoGenomics finalized a civil settlement with the U.S. Department of Justice on behalf of the OIG-HHS, resolving a government investigation into consulting services provided to healthcare providers. The Company agreed to pay $9,813,260 to resolve the matter. This is a material government settlement arising from a regulatory investigation into potential healthcare fraud and abuse compliance issues, which would materially affect a reasonable investor's assessment of the registrant's legal and financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T21:28:39.785133+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17831,"accession_number":"0001077183-26-000045","item_number":"7.01","item_title":null,"event_type":"legal_other","event_domain":"legal","is_material":true,"confidence":0.85,"reasoning":"NeoGenomics announced settlement of a DOJ/OIG investigation concerning consulting services provided under its Laboratory Collaboration Initiative program. The company agreed to pay $9,813,260 plus interest, resolving a matter it had self-disclosed in November 2021 and for which it had previously accrued $11.2 million in reserves. This is a material legal settlement with a government agency that would affect a reasonable investor's assessment of the company's regulatory compliance and financial position, but does not fit the specific \"material_litigation\" category (which typically involves private lawsuits or settlements) — it is instead a regulatory settlement, making \"legal_other\" the most appropriate classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T21:28:39.785133+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-07-20"},{"id":17832,"accession_number":"0001077183-26-000045","item_number":"8.01","item_title":null,"event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.95,"reasoning":"NeoGenomics finalized a civil settlement with the U.S. Department of Justice on behalf of the OIG-HHS, resolving a government investigation into consulting services provided to healthcare providers. The Company agreed to pay $9,813,260 to resolve the matter. This is a material government settlement arising from a regulatory investigation into potential healthcare fraud and abuse compliance issues, which would materially affect a reasonable investor's assessment of the registrant's legal and financial position.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-20T21:28:39.785133+00:00","company_name":"NEOGENOMICS INC","ticker":"NEO","filing_date":"2026-07-20"}]}
